Sign in

You're signed outSign in or to get full access.

Michael Allan Domb

Independent Trustee at UNIVERSAL HEALTH REALTY INCOME TRUST
Board

About Michael Allan Domb

Independent Trustee (Class III) since 2017; age 70. Owner of Allan Domb Real Estate, a multi-faceted firm in Center City Philadelphia focused on brokerage, development, investment and management across residential and commercial properties; previously Philadelphia Councilmember At-Large (2015–Aug 2022). Provides real estate and investment expertise to the Board; currently serves on the Compensation Committee and is nominated for re-election for a term through the 2028 annual meeting.

Past Roles

OrganizationRoleTenureCommittees/Impact
Allan Domb Real EstateOwnerOngoingReal estate development, brokerage, investment leadership in Philadelphia
Greater Philadelphia Association of RealtorsPresident2013–2015Industry leadership and advocacy
City of PhiladelphiaCouncilmember At-Large2015–Aug 2022Municipal governance; resigned Aug 2022

External Roles

OrganizationRoleTenurePublic Company?
Allan Domb Real EstateOwnerOngoingPrivate firm (no public directorship disclosed)

Board Governance

  • Committee assignments: Compensation Committee member; committee met once in 2024 and is chaired by James P. Morey (since March 2025; Gayle L. Capozzalo chaired in 2024). Domb is not listed as a chair.
  • Independence: Board determined Domb is “independent” under SEC and NYSE standards; majority-independent Board (5 of 7 trustees).
  • Tenure and class: Class III trustee; term expiring at 2025 annual meeting; nominated for re-election to a term ending 2028.
  • Attendance and engagement: Board held four regular meetings in 2024; “all active Trustees participated in substantially all” Board and applicable committee meetings; Independent Trustees held four executive sessions; all Trustees attended the 2024 annual meeting.
  • Board leadership: Lead Independent Trustee is Robert F. McCadden; Audit Committee met ten times in 2024.
  • Governance policies: Prohibition on hedging (collars, forwards, options) by trustees; clawback policy adopted Oct 2, 2023 for executive officers; insider trading policy filed with 2024 Form 10-K.

Fixed Compensation

Component (2024)Amount ($)Notes
Annual retainer (pro rata)31,142Retainer increased from $30,000 to $32,000 on June 6, 2024; Domb’s pro rata for 2024 totaled $31,142
Committee membership fee (Compensation Committee)500Compensation Committee membership retainer
Total fees earned in cash31,642Sum of retainer and committee fees
Travel reimbursementsN/ATravel expenses reimbursed if applicable; amounts not itemized

Performance Compensation

Equity Award Detail (2024)Value
Restricted stock grant (shares)785 shares
Grant dateJune 5, 2024
Grant-date fair value$30,018 ($38.24 per share)
VestingSecond anniversary of grant date (service-based)
Dividends on unvested RSDeferred and paid at vesting on shares that vest
Option awards$0 (none granted to trustees)
Total 2024 equity compensation (trustee table)$30,018

No director-specific performance metrics (e.g., TSR targets) tied to trustee equity grants are disclosed; vesting is service-based, while the plan permits performance conditioning primarily for NEO awards.

Other Directorships & Interlocks

CategoryDetail
Other public company boardsNone disclosed in proxy biography for Domb
Compensation Committee interlocksNone; all members independent; no member served as an officer/employee or had relationships requiring disclosure in 2024

Expertise & Qualifications

  • Real estate investment/development and brokerage; mixed-use, multifamily, office, and restaurant assets.
  • Public sector experience as Philadelphia Councilmember At-Large (2015–Aug 2022).
  • Board states he provides expertise on real estate matters and business investments.

Equity Ownership

ItemValue
Beneficial ownership (as of Mar 31, 2025)11,529 shares
Ownership % of shares outstandingLess than 1%
Shares outstanding (record date Apr 14, 2025)13,851,469 shares
Vested vs unvestedIncludes restricted shares awarded in 2023 and 2024 scheduled to vest in 2025 and 2026
Pledged sharesNone; “No shares are pledged as security by any of our Trustees or executive officers.”
Hedging policyTrustees prohibited from hedging Trust stock (options, collars, forwards)

Governance Assessment

  • Positive signals: Independent trustee with relevant real estate domain expertise; shares owned and annual RS grants align director interests with shareholders; no pledging and hedging prohibited; strong say‑on‑pay support historically (93–94%) indicating investor confidence in compensation governance.
  • Engagement: Board/committee participation described as “substantially all”; independent executive sessions after each regular meeting; Audit Committee active (10 meetings in 2024).
  • Potential conflicts (structural): UHT’s significant related‑party relationships with UHS (advisor agreement; UHS‑related tenants and hospital leases comprising ~40% of revenue in recent years) require vigilant independent oversight; transactions with UHS must be approved by Independent Trustees per Declaration of Trust.
  • Watch items: Compensation Committee met once in 2024 (frequency light vs Audit); continued monitoring of committee workload and breadth of performance conditioning for director equity could strengthen alignment.

Director Compensation (Summary Table, 2024)

NameFees Earned or Paid in Cash ($)Stock Awards ($)Option Awards ($)All Other Compensation ($)Total ($)
Michael Allan Domb31,642 30,018 3,865 (dividends accrued on unvested RS) 65,525

Say‑on‑Pay & Shareholder Feedback (Context)

  • Say‑on‑pay support increased to 94% in 2023 (tabulated at June 2024 annual meeting), and 93% in 2022 and 2021, following enhanced disclosures on advisory fee and NEO compensation structure.